2Telkova IL,Tepliakov AT,Karpov RS,et al.Possible role of hyperinsulinemia in pathogenesis of acute and chronic cardiac failure in patients with ischemic heart disease (data of clinical studies)[J].Kardiologiia,2006,46(6):43-48. 被引量：1
3Pitt B,Bakris G,Ruilope LM,et al.Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS)[J].Circulation,2008,118(16):1643-1650. 被引量：1
4Raos V,Raguz M,Rajcan Spoljari I,et al.Anti-ischemic therapy in patients with STEMI or NSTEMI treated at county and university hospitals[J].Acta Med Croatica,2009,63(1):53-58. 被引量：1
5Pisarenko OI,Serebriakova LI,Tsikitishvili OV,et al.Attenuation of irreversible rat heart injury by reperfusion with metabolic protectors[J].Biomed Khim,2008,54(6):659-670. 被引量：1
6Nishimura M,Tokoro T,Nishida M,et al.Clinical potential of nicorandil to inhibit major cardiac events in hemodialysis patients with suspected myocardial ischemia[J].Nephron Clin Pract,2009,111(3):212-221. 被引量：1
7Kang CS,Chen CC,Lin CC,et al.Effect of ATP-sensitive potassium channel agonists on sympathetic hyperinnervation in postinfarcted rat hearts[J].Am J Physiol Heart Circ Physiol,2009,296(6):H1949-1959. 被引量：1
